BRKR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BRKR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bruker's Free Cash Flow for the three months ended in Sep. 2024 was $6 Mil. Bruker's Revenue for the three months ended in Sep. 2024 was $864 Mil. Therefore, Bruker's FCF Margin % for the quarter that ended in Sep. 2024 was 0.67%.
As of today, Bruker's current FCF Yield % is 1.79%.
The historical rank and industry rank for Bruker's FCF Margin % or its related term are showing as below:
During the past 13 years, the highest FCF Margin % of Bruker was 12.01%. The lowest was 4.45%. And the median was 7.32%.
The historical data trend for Bruker's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bruker Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
FCF Margin % | Get a 7-Day Free Trial | 6.77 | 11.82 | 7.87 | 5.74 | 8.20 |
Bruker Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
FCF Margin % | Get a 7-Day Free Trial | 2.32 | 20.36 | 0.06 | -2.93 | 0.67 |
For the Medical Devices subindustry, Bruker's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Bruker's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Bruker's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Bruker's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
FCF Margin | = | Free Cash Flow (A: Dec. 2023 ) | / | Revenue (A: Dec. 2023 ) |
= | 243.2 | / | 2964.5 | |
= | 8.20 % |
Bruker's FCF Margin for the quarter that ended in Sep. 2024 is calculated as
FCF Margin | = | Free Cash Flow (Q: Sep. 2024 ) | / | Revenue (Q: Sep. 2024 ) |
= | 5.8 | / | 864.4 | |
= | 0.67 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Bruker's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard A Packer | director | 9 KENDALL DRIVE, WESTBOROUGH MA 01581 |
Frank H Laukien | director, 10 percent owner, officer: CEO, President | C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821 |
Bob Rosenthal | director | 20 NEWBURY ST, BOSTON MA 02116 |
Hermann Fritz Requardt | director | C/O BRUKER CORP., 40 MANNING ROAD, BILLERICA MA 01821 |
Burkhard Prause | officer: Pres. & CEO, Bruker EST | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Marc A Kastner | director | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Cynthia M Friend | director | C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Philip Ma | director | C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Mark Munch | officer: Pres. Bruker Nano Inc. | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Juergen Srega | officer: Group President Bruker CALID | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Bonnie H Anderson | director | 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080 |
Martin Gilles Gerard Jean | director | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Falko Busse | officer: President, BioSpin Group | 40 MANNING ROAD, BILLERICA MA 01821 |
Gerald N Herman | officer: Vice President, Corp Contr. | 55 EXECUTIVE DRIVE, HUDSON NH 03051 |
Ingen Chris Van | director | 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306 |
From GuruFocus
By GuruFocus News • 11-14-2024
By Business Wire • 10-11-2024
By Marketwired • 10-17-2024
By Business Wire • 10-02-2024
By Khac Phu Nguyen • 11-20-2024
By Business Wire • 11-05-2024
By GuruFocus Research • 10-01-2024
By Business Wire • 11-12-2024
By GuruFocus News • 11-06-2024
By GuruFocus News • 11-05-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.